ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,433.76
0.63%
Dow Jones
39,512.84
0.32%
Gold vs US Dollar
2,360.48
0.00%
Brent Oil
82.585
0.00%
Bitcoin
60,930.59
0.22%
Pepperstone
Advertisement
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. AMEX
  6. Goldfield Corp (GV)

  7. Goldfield Corp (GV) News

Goldfield (GV)

Goldfield Corp
Date:
Sort by:
 Showing the most relevant articles for your search:AMEX:GV
DateTimeSourceHeadlineSymbolCompany
24/01/202307:00Business WireGenomic Vision renforce sa direction en accueillant Frédéric Hammel au poste de Directeur des OpérationsAMEX:GVGoldfield Corp
24/01/202307:00Business WireGenomic Vision Strengthens Leadership Team With the Appointment of Frederic Hammel as Chief Operating OfficerAMEX:GVGoldfield Corp
13/01/202316:45Business WireGenomic Vision : Bilan semestriel du Contrat de Liquidité contracté avec CM-CIC SecuritiesAMEX:GVGoldfield Corp
05/01/202306:00Business WireGenomic Vision Announces Successful Beta Testing of FiberSmart®AMEX:GVGoldfield Corp
05/01/202306:00Business WireGenomic Vision annonce la réussite du bêta test de FiberSmart®AMEX:GVGoldfield Corp
29/11/202207:00Business WireGenomic Vision’s Cutting-Edge TeloSizer® Application to be Used in Cancer ResearchAMEX:GVGoldfield Corp
29/11/202207:00Business WireTeloSizer®, application de pointe développée par Genomic Vision, mise au service de la recherche sur le cancerAMEX:GVGoldfield Corp
10/11/202216:45Business WireGenomic Vision : Nombre total d’actions et de droits de voteAMEX:GVGoldfield Corp
07/11/202206:00Business WireGenomic Vision and Cambridge Consultants, Part of Capgemini, Announce the Development of an Innovative Technology Platform for In-depth Genomic AnalysisAMEX:GVGoldfield Corp
07/11/202206:00Business WireGenomic Vision et Cambridge Consultants, filiale de Capgemini, annoncent le développement d'une plateforme technologique innovante dédiée à l'analyse génomiqueAMEX:GVGoldfield Corp
27/10/202217:00Business WireGenomic Vision : Information financière du 3ème trimestre 2022AMEX:GVGoldfield Corp
27/10/202217:00Business WireGenomic Vision: Financial Information for the Third Quarter of 2022AMEX:GVGoldfield Corp
24/10/202206:30Business WireGenomic Vision : communiqué relatif aux changements au sein de la gouvernanceAMEX:GVGoldfield Corp
24/10/202206:30Business WireGenomic Vision: Press Release Regarding Changes in the Company’s GovernanceAMEX:GVGoldfield Corp
29/09/202217:00Business WireGENOMIC VISION : RÉSULTATS SEMESTRIELS 2022AMEX:GVGoldfield Corp
29/09/202217:00Business WireGenomic Vision: First-half 2022 ResultsAMEX:GVGoldfield Corp
06/09/202217:00Business WireGenomic Vision Announces the Issuance of the 1st Tranche of Convertible Notes With Warrants (OCABSA) for €2 Million, as Part of the Financing Line Concluded With Winance for a Maximum Amount of €30 MillionAMEX:GVGoldfield Corp
06/09/202217:00Business WireGenomic Vision annonce le tirage de la 1ère tranche de 2 M€ dans le cadre du programme de financement conclu avec Winance pour un montant maximum de 30 M€AMEX:GVGoldfield Corp
22/07/202217:29Business WireGenomic Vision: Financial Information for the First Half of 2022AMEX:GVGoldfield Corp
22/07/202217:29Business WireGenomic Vision : Information financière du 1er semestre 2022AMEX:GVGoldfield Corp
18/07/202206:00Business WireGENOMIC VISION : Apport complémentaire au contrat de liquidité conclu avec CM-CIC SecuritiesAMEX:GVGoldfield Corp
18/07/202206:00Business WireGenomic Vision: Additional Contribution to the Liquidity Contract Concluded with CM-CIC SecuritiesAMEX:GVGoldfield Corp
13/07/202217:00Business WireGenomic Vision: Changes in the Company’s GovernanceAMEX:GVGoldfield Corp
13/07/202217:00Business WireGenomic Vision : changements au sein de la gouvernanceAMEX:GVGoldfield Corp
07/07/202216:45Business WireGenomic Vision : Bilan semestriel du Contrat de Liquidité contracté avec CM-CIC SecuritiesAMEX:GVGoldfield Corp
27/06/202217:00Business WireGenomic Vision: Report de l’assemblée générale ordinaire des actionnaires du 28 juin 2022AMEX:GVGoldfield Corp
23/06/202217:00Business WireGenomic Vision Obtains the Renewal of the ISO 13485 : 2016 CertificationAMEX:GVGoldfield Corp
23/06/202217:00Business WireGenomic Vision obtient le renouvellement de sa certification ISO 13485 : 2016AMEX:GVGoldfield Corp
16/06/202218:30Business WireGenomic Vision obtient un nouveau brevet pour sa technique de « Caractérisation Physique des télomères » basée sur le peignage moléculaireAMEX:GVGoldfield Corp
16/06/202218:30Business WireGenomic Vision granted a new patent for its “Physical Characterization of Telomeres” technique based on molecular combingAMEX:GVGoldfield Corp
 Showing the most relevant articles for your search:AMEX:GV

Your Recent History

LSE
PET
Petrel Resources
LSE
VAST
Vast Resources
LSE
PANR
Pantheon Resources
LSE
RR.
Rolls-royce
LSE
ITV
Itv
LSE
AGL
Angle
LSE
TERN
Tern
LSE
RKH
Rockhopper Exploration
LSE
KEFI
Kefi Gold And Copper
LSE
TXP
Touchstone Exploration
LSE
GDR
Genedrive
LSE
BARC
Barclays
LSE
SAR
Sareum
LSE
CHLL
Chill Brands
LSE
CEG
Challenger Energy
LSE
SCE
Surface Transforms
Delayed Upgrade Clock
    ADVFN Logo

    United Kingdom
    Company
    Business
    Popular
    Get The App

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved